About Dynal Biotech
Dynal Biotech is a company based in Carlsbad (United States) founded in 2000 was acquired by Invitrogen in February 2005. Dynal Biotech has raised $27.58 million across 1 funding round from investors including Ratos and Invitrogen. Dynal Biotech operates in a competitive market with competitors including NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
- Headquarter Carlsbad, United States
- SectorsHealthcare
- Website dynalbiotech.com
- Social LinkedIn
- Acquired by Invitrogen (Feb 2005)
- Total Equity Funding$27.58M (USD)
in 1 rounds
- Latest Funding Round$27.58M (USD), Private Equity Round
Oct 2001
- InvestorsRatos
& 1 more
- Acquired byInvitrogen
(Feb 2005)
Funding Insights of Dynal Biotech
Dynal Biotech has successfully raised a total of $27.58M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $27.58 million completed in October 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27.58M
- Total Rounds 1
- Last Round Private Equity Round — $27.58M
- First Round $27.58M
(Oct 2001)
- Investors Count 1
All 1 funding rounds of Dynal Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2001 | $27.58M | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Dynal Biotech
Dynal Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ratos and Invitrogen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on consumer, industry, construction, and services sectors | 1866 | ratos.com | Stockholm, Sweden | |
Provider of scientific instruments, services, and consumables | 1987 | invitrogen.com | Carlsbad, United States |
Investor details for Dynal Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Dynal Biotech
3 dated milestones of Dynal Biotech across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Dynal Biotech is founded.
- Funding First funding round of $27.6M.
- Exit Acquired by Invitrogen.
Competitors of Dynal Biotech
Dynal Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanocellect.com | 2009 | San Diego, United States | $78.15M | 84 | Develops flow cytometry and cell sorting technology | |
| thinkcyte.com | 2016 | Bunkyo, Japan | $83.18M | – | Cell analysis and sorting technologies are developed with AI integration. | |
| singulex.com | 1997 | Alameda, United States | $140.94M | 236 | Single-molecule counting technology is developed for cardiovascular biomarker detection. | |
| cellmicrosystems.com | 2009 | Durham, United States | $19.1M | – | Developer of a technology to isolate and recover single cells for molecular analysis | |
| siliconbiosystems.com | 1999 | Bologna, Italy | $25.53M | – | Lab-on-a-chip technologies for miniaturized cell-biology testing are developed. | |
| immunicon.com | 1983 | Bryn Athyn, United States | $75.35M | – | Cell and molecular-based diagnostics for cancer management are developed. | |
| fdsonics.com | 2010 | Wilbraham, United States | $34.82M | 7 | Developer of acoustic particle trapping systems for applications in research and public health | |
| cytomos.com | 2012 | Edinburgh, United Kingdom | $13.55M | 15 | Point-of-care cell sorter is developed for research and diagnostics. | |
| cytena.com | 2014 | – | $4.59M | 71 | Single cells are isolated using the cy-Clone device technology. | |
| nodexus.com | 2014 | Berkeley, United States | $31.2M | 27 | Microfluidic systems are developed for detecting metastatic cancer. |
Detailed competitors of Dynal Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Dynal Biotech
10 companies that operate in the same segment as Dynal Biotech (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dynal Biotech
Dynal Biotech was founded in 2000 and raised its 1st funding round 1 year after it was founded.
Dynal Biotech is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Dynal Biotech is a funded company, having raised a total of $27.58M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $27.58M, raised on Oct 2001.
Dynal Biotech was founded in 2000 in Carlsbad, United States, focusing on biotechnology for molecular purification and separation. Spherical polystyrene beads were utilized to facilitate magnetic and non-magnetic separation of targeted cells. The company was acquired by Nordic Capital and Ratos Sweden in October 2001. In April 2005, acquisition by Invitrogen occurred for 300 million, followed by Invitrogens purchase by ThermoFisher.
Dynal Biotech's top competitors include NanoCellect Biomedical, ThinkCyte and Silicon Biosystems.
Dynal Biotech has 2 investors. Key investors include Ratos, and Invitrogen.
Yes. Dynal Biotech was acquired by Invitrogen in February 2005.